University of Pennsylvania 12th annual conference on statistical issues in clinical trials: Electronic health records in randomized clinical trials—challenges and opportunities (morning panel session)

Abstract

Get full access to this article

View all access options for this article.

References

Bhasin

Gill

Reuben

, et al. Strategies to reduce and develop confidence in elders (STRIDE): a cluster-randomized pragmatic trial of a multifactorial fall injury prevention strategy: design and methods. J Gerontol A Biol Sci Med Sci 2018; 73(8): 1053–1061.

Baiocchi

Small

Yang

, et al. Near/far matching: a study design approach to instrumental variables. Health Serv Outcomes Res Methodol 2012; 12(4): 237–253.

Zeliadt

Coggeshall

Gelman

, et al. The APPROACH trial: assessing pain, patient reported outcomes and complementary and integrative health. Clin Trials. IN PRESS.

US Food & Drug Administration. Framework for FDA’s real-world evidence program, https://www.fda.gov/media/120060/download (2018; accessed 1 November 2019).

RCT Duplicate. Randomized controlled trials duplicated using prospective longitudinal insurance claims: applying techniques of epidemiology, https://www.rctduplicate.org/ (2019, accessed 10 November 2019).

Treweek

Sullivan

Loudon

, et al. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 2015; 350: h2147.

Aspirin dosing: a patient-centric trial assessing benefits and long-term effectiveness (ADAPTABLE), https://clinicaltrials.gov/ct2/show/NCT02697916 (2016, accessed 10 November 2019).

PCORnet the National Patient-Centered Clinical Research Network, https://pcornet.org/ (2019, accessed 10 November 2019).

Green

Hernandez

D’Agostino

, et al. Harmony outcomes: a randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus—rationale, design, and baseline characteristics. Am Heart J 2018; 203: 30–38.

10.

Kesselheim

Avorn

Fralick

, et al. Use of health care databases to support supplemental indications of approved medications. JAMA Intern Med 2018; 178(1): 55–63.

11.

Schneeweiss

Gopalakrishnan

Patorno

, et al. Using real-world data to predict findings of an ongoing phase IV cardiovascular outcome trial: cardiovascular safety of linagliptin versus glimepiride. Diabetes Care 2019; 42(12): 2204–2210.

12.

Pawar

Martin

Franklin

, et al. Nonrandomized real-world evidence to support regulatory decision making: process for a randomized trial replication project. Clin Pharmacol Ther 2020; 107(4): 817–826.